Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Type 4 Phosphodiesterase Inhibitors Attenuate Respiratory Syncytial Virus-Induced Airway Hyper-Responsiveness and Lung Eosinophilia
Toshihide Ikemura, Jurgen Schwarze, Mika Makela, Arihiko Kanehiro, Anthony Joetham, Kenji Ohmori and Erwin W. Gelfand
Journal of Pharmacology and Experimental Therapeutics August 2000, 294 (2) 701-706;
Toshihide Ikemura
Jurgen Schwarze
Mika Makela
Arihiko Kanehiro
Anthony Joetham
Kenji Ohmori
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 294, Issue 2
1 Aug 2000
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Type 4 Phosphodiesterase Inhibitors Attenuate Respiratory Syncytial Virus-Induced Airway Hyper-Responsiveness and Lung Eosinophilia
Toshihide Ikemura, Jurgen Schwarze, Mika Makela, Arihiko Kanehiro, Anthony Joetham, Kenji Ohmori and Erwin W. Gelfand
Journal of Pharmacology and Experimental Therapeutics August 1, 2000, 294 (2) 701-706;
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
Type 4 Phosphodiesterase Inhibitors Attenuate Respiratory Syncytial Virus-Induced Airway Hyper-Responsiveness and Lung Eosinophilia
Toshihide Ikemura, Jurgen Schwarze, Mika Makela, Arihiko Kanehiro, Anthony Joetham, Kenji Ohmori and Erwin W. Gelfand
Journal of Pharmacology and Experimental Therapeutics August 1, 2000, 294 (2) 701-706;
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement